Benzinga - by Lisa Levin, Benzinga Editor.
The Dow Jones closed lower by more than 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
Eos Energy Enterprises
- The Trade: Eos Energy Enterprises, Inc. (NASDAQ: EOSE) CEO Joe Mastrangelo acquired a total of 36,500 shares an average price of $2.05. To acquire these shares, it cost around $74,810.
- What’s Happening: Eos was selected by Dominion Energy Virginia to provide 16 MWh of storage in a pilot project to strengthen the region's electrical grid.
- What Eos Energy Enterprises Does: Eos Energy Enterprises Inc designs develop, manufactures, and markets innovative zinc-based energy storage solutions for utility-scale, microgrid, and commercial & industrial (C&I) applications.
- The Trade: Cadiz Inc. (NASDAQ: CDZI) Executive Director Susan Kennedy acquired a total of 15,822 shares at an average price of $3.17. The insider spent around $50,156.
- What’s Happening: The company’s stock lost 8% over the past month.
- What Cadiz Does: Cadiz Inc is a land and water resource development company in California. Its primary business is to acquire and develop land with water resources for various uses, including groundwater supply, groundwater storage, and agriculture.
- The Trade: Fluent, Inc. (NASDAQ: FLNT) 10% owner Frost Gamma Investments Trust acquired a total of 100,000 shares at an average price of $0.46. To acquire these shares, it cost around $46,000.
- What’s Happening: Fluent posted downbeat quarterly sales.
- What Fluent Does: Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers they are seeking to reach.
Don’t forget to check out our premarket coverage here
Nuvation Bio
- The Trade: Nuvation Bio Inc. (NYSE: NUVB) Director Biotech Opportunity GP, LLC acquired a total of 5,313,100 shares at an average price of $1.26. The insider spent $6.69 million to buy those shares.
- What’s Happening: Nuvation Bio posted a narrower-than-expected quarterly loss.
- What Nuvation Bio Does: Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates.